Raymond James & Associates Increases Stake in TransCanada Co. (TRP)

Raymond James & Associates grew its holdings in TransCanada Co. (NYSE:TRP) (TSE:TRP) by 7.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 72,821 shares of the pipeline company’s stock after buying an additional 5,347 shares during the quarter. Raymond James & Associates’ holdings in TransCanada were worth $3,544,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Bollard Group LLC increased its stake in shares of TransCanada by 1.0% in the fourth quarter. Bollard Group LLC now owns 110,317 shares of the pipeline company’s stock valued at $5,366,000 after buying an additional 1,133 shares in the last quarter. K.J. Harrison & Partners Inc increased its stake in shares of TransCanada by 27.4% in the fourth quarter. K.J. Harrison & Partners Inc now owns 5,449 shares of the pipeline company’s stock valued at $266,000 after buying an additional 1,172 shares in the last quarter. SG Americas Securities LLC increased its stake in shares of TransCanada by 20.4% in the third quarter. SG Americas Securities LLC now owns 9,426 shares of the pipeline company’s stock valued at $466,000 after buying an additional 1,599 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its stake in shares of TransCanada by 37.4% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 5,910 shares of the pipeline company’s stock valued at $288,000 after buying an additional 1,610 shares in the last quarter. Finally, First Trust Advisors LP increased its stake in shares of TransCanada by 30.6% in the third quarter. First Trust Advisors LP now owns 8,924 shares of the pipeline company’s stock valued at $441,000 after buying an additional 2,092 shares in the last quarter. Institutional investors own 58.84% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of TRP stock opened at $41.99 on Friday. The company has a debt-to-equity ratio of 1.70, a current ratio of 0.47 and a quick ratio of 0.44. The stock has a market capitalization of $35,331.83, a P/E ratio of 17.64, a PEG ratio of 1.91 and a beta of 0.63. TransCanada Co. has a 12 month low of $39.16 and a 12 month high of $51.85.

TransCanada (NYSE:TRP) (TSE:TRP) last announced its quarterly earnings data on Thursday, February 15th. The pipeline company reported $0.65 EPS for the quarter, topping the Zacks’ consensus estimate of $0.58 by $0.07. The firm had revenue of $2.85 billion during the quarter, compared to analyst estimates of $1.96 billion. TransCanada had a return on equity of 12.33% and a net margin of 23.40%. equities analysts anticipate that TransCanada Co. will post 2.57 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 30th. Investors of record on Thursday, March 29th will be given a $0.5486 dividend. This represents a $2.19 dividend on an annualized basis and a yield of 5.23%. This is a positive change from TransCanada’s previous quarterly dividend of $0.49. The ex-dividend date of this dividend is Wednesday, March 28th. TransCanada’s dividend payout ratio (DPR) is presently 92.86%.

A number of analysts have recently weighed in on TRP shares. Morgan Stanley upgraded TransCanada from an “equal weight” rating to an “overweight” rating and set a $54.00 target price for the company in a research note on Thursday, January 11th. They noted that the move was a valuation call. Citigroup lowered their target price on TransCanada from $71.00 to $68.00 and set a “buy” rating for the company in a research note on Wednesday, March 28th. Zacks Investment Research lowered TransCanada from a “buy” rating to a “hold” rating in a research note on Tuesday, January 23rd. Wells Fargo lowered TransCanada from an “outperform” rating to a “market perform” rating in a research report on Thursday, March 22nd. Finally, Bank of America assumed coverage on TransCanada in a research report on Tuesday, January 9th. They issued a “buy” rating for the company. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $58.40.

COPYRIGHT VIOLATION WARNING: “Raymond James & Associates Increases Stake in TransCanada Co. (TRP)” was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark laws. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3334448/raymond-james-associates-increases-stake-in-transcanada-co-trp.html.

TransCanada Profile

TransCanada Corporation operates as an energy infrastructure company in North America. It operates through Canadian Natural Gas Pipelines, U.S. Natural Gas Pipelines, Mexico Natural Gas Pipelines, Liquids Pipelines, and Energy segments. The company transports natural gas to local distribution companies, power generation and individual facilities, interconnecting pipelines, and other businesses.

Want to see what other hedge funds are holding TRP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TransCanada Co. (NYSE:TRP) (TSE:TRP).

Institutional Ownership by Quarter for TransCanada (NYSE:TRP)

Receive News & Ratings for TransCanada Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransCanada and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Tezos   Hits 24 Hour Trading Volume of $775,031.00
Tezos Hits 24 Hour Trading Volume of $775,031.00
Renos  One Day Trading Volume Tops $3,382.00
Renos One Day Trading Volume Tops $3,382.00
Piper Jaffray Reiterates “Buy” Rating for Royal Dutch Shell
Piper Jaffray Reiterates “Buy” Rating for Royal Dutch Shell
Sarepta Therapeutics  Earns Buy Rating from HC Wainwright
Sarepta Therapeutics Earns Buy Rating from HC Wainwright
Artesian Resources  Given News Impact Score of 0.07
Artesian Resources Given News Impact Score of 0.07
eHealth  to Release Earnings on Wednesday
eHealth to Release Earnings on Wednesday


© 2006-2018 Ticker Report. Google+.